KCNH2 and cardiac arrest: These factors include but are not limited to the specific location of pathogenic gene mutations (e.g., transmembrane region versus C-loop mutations in LQT1, pore ring versus non-pore ring mutations in LQT2); patients’ history of prior cardiac events (e.g., prior cardiac arrest being a strong predictor of future events); and gender.